Kazia Therapeutics (KZIA) Current Deferred Revenue (2017 - 2018)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Kazia Therapeutics' Current Deferred Revenue history spans 2 years, with the latest figure at $104471.1 for Q2 2018.

• For Q2 2018, Current Deferred Revenue rose 239.2% year-over-year to $104471.1; the TTM value through Jun 2018 reached $104471.1, up 239.2%, while the annual FY2018 figure was $104471.1, 239.2% up from the prior year.
• Current Deferred Revenue reached $104471.1 in Q2 2018 per KZIA's latest filing, up from $30799.6 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $104471.1 in Q2 2018 to a low of $30799.6 in Q2 2017.

Peer Comparison